MEDOF (Medios AG) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 05, 2026)


MEDOF Medios AG MEDOF
88 GF Score
Price $50.00
GF Value $70.33
! 2 Warning Signs
View Full Analysis

What is Medios AG 5-Year Yield-on-Cost %?

Medios AG MEDOF 88 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $70.33. The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, Medios AG ranks worse than 1449273.91% on this metric.

Medios AG's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Medios AG's 5-Year Yield-on-Cost % or its related term are showing as below:



MEDOF's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.33
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Medios AG  (OTCPK:MEDOF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Medios AG 5-Year Yield-on-Cost % Related Terms


MEDOF vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison

For the Medical Distribution subindustry, Medios AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medios AG 5-Year Yield-on-Cost % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medios AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medios AG's 5-Year Yield-on-Cost % falls into.


MEDOF
88GF Score
Medios AG MEDOF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medios AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medios AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Medios AG (MEDOF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medios AG and its competitors. According to the industry distribution chart, Medios AG ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Medios AG's 5-Year Yield-on-Cost % too high?
Medios AG's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Medios AG ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #999999 out of 69 companies for 5-Year Yield-on-Cost %. This places Medios AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.33, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $70.33, compared to a current price of $50.00 — trading 28.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medios AG (MEDOF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medios AG (MEDOF) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of $50.00 is trading 28.9% below its estimated GF Value™ of $70.33.

Key valuation signals for MEDOF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $70.33 vs. price of $50.00 (28.9% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for MEDOF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.00
Price
$70.33
GF Value